Pfizer: all 4,072 studies
Page 10 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate PF-04965842 in Patients With Moderate to Severe PsoriasisTerminatedNCT02201524Phase 2Results posted
- Randomized, Placebo Controlled Study Of The Efficacy And Safety Of PF-02545920 In Subjects With Huntington's DiseaseCompletedNCT02197130Phase 2Results posted
- A 12 Day Study To Evaluate A Topical Drug To Treat Plaque PsoriasisCompletedNCT02193815Phase 1Results posted
- Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in PsoriasisCompletedNCT02192164Results posted
- A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04)CompletedNCT02187744Phase 3Results posted
- An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With MethotrexateCompletedNCT02187055Phase 4Results posted
- Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First LineCompletedNCT02187042Results posted
- Efficacy, Safety And Tolerability Of PF-06743649 In Gout Subjects.TerminatedNCT02187029Phase 1Results posted
- A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036)CompletedNCT02179918Phase 1Results posted
- Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes MellitusCompletedNCT02175121Phase 2Results posted
- LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF MelanomaCompletedNCT02159066Phase 2Results posted
- Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South KoreaCompletedNCT02156895Results posted
- A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background MethotrexateCompletedNCT02147587Phase 2Results posted
- Vyndaqel Drug Use Investigation (Regulatory Post Marketing Commitment Plan)CompletedNCT02146378Results posted
- Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to StatinsCompletedNCT02135029Phase 3Results posted
- A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell CancerCompletedNCT02133742Phase 1Results posted
- A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT02130557Phase 3Results posted
- A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid TumorsTerminatedNCT02129205Phase 1Results posted
- Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.CompletedNCT02124161Phase 4Results posted
- A Study Of PF-06664178 In Patients With Advanced Solid TumorsTerminatedNCT02122146Phase 1Results posted
- Prevenar (13v) Infant Drug Use InvestigationCompletedNCT02119104Results posted
- Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic DermatitisCompletedNCT02118792Phase 3Results posted
- Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic DermatitisCompletedNCT02118766Phase 3Results posted
- A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.CompletedNCT02117570Phase 2Results posted
- Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Study Of PF-04447943, Co-Administered With And Without Hydroxyurea, In Subjects With Stable Sickle Cell DiseaseCompletedNCT02114203Phase 1Results posted
- Study Of PF-03084014 In Combination With Gemcitabine And Nab-Paclitaxel In Patients With Metastatic Pancreatic Adenocarcinoma Not Previously Treated With Anticancer TherapiesTerminatedNCT02109445Phase 2Results posted
- Post Marketing Surveillance Study For Sayana®CompletedNCT02104557Results posted
- Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With PainTerminatedNCT02101554Phase 4Results posted
- Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular EventsCompletedNCT02100514Phase 3Results posted
- Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)CompletedNCT02100228Phase 4Results posted
- Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid ArthritisCompletedNCT02092467Phase 4Results posted
- A Study Of PF-06647263 In Patients With Advanced Solid TumorsTerminatedNCT02078752Phase 1Results posted
- Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese SubjectsCompletedNCT02055976Phase 2Results posted
- A Study To Evaluate The Safety And Tolerability Of PF-06342674 (RN168) In Subjects With Multiple Sclerosis (MS)TerminatedNCT02045732Phase 1Results posted
- A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking CessationCompletedNCT02044874Phase 2Results posted
- Pharmacokinetics And Relative Bioavailability Of Bococizumab (PF-04950615; RN316) When Administered To The Abdomen, Thigh Or Upper ArmCompletedNCT02043301Phase 1Results posted
- A Study Of PF-04449913 In Japanese Patients With Select Hematologic MalignanciesCompletedNCT02038777Phase 1Results posted
- A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 DiabetesCompletedNCT02038764Phase 1Results posted
- A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)TerminatedNCT02034916Phase 2Results posted
- 13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in IndiaCompletedNCT02034877Phase 4Results posted
- A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy VolunteersCompletedNCT02014272Phase 1Results posted
- Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast CancerCompletedNCT02007512Phase 2Results posted
- Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate CancerCompletedNCT02003924Phase 3Results posted
- Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsCompletedNCT02001623Phase 1/2Results posted
- Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)CompletedNCT02001181Phase 2Results posted
- A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid TumorsCompletedNCT01999972Phase 1Results posted
- Safety Study of Continued Enzalutamide Treatment In Prostate Cancer PatientsCompletedNCT01995513Phase 4Results posted
- Safety and Efficacy of Tafamidis in Patients With Transthyretin CardiomyopathyCompletedNCT01994889Phase 3Results posted
- A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular EdemaTerminatedNCT01994291Phase 2Results posted
- A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)CompletedNCT01989676Phase 3Results posted
- Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or InfliximabCompletedNCT01981473Results posted
- LGX818 for Patients With BRAFV600 Mutated TumorsTerminatedNCT01981187Phase 2Results posted
- Open-Label Extension Study Of Tofacitinib In Psoriatic ArthritisCompletedNCT01976364Phase 3Results posted
- The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsTerminatedNCT01975389Phase 3Results posted
- The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk SubjectsTerminatedNCT01975376Phase 3Results posted
- A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular AlterationsCompletedNCT01970865Phase 1/2Results posted
- A 52 Week Study To Assess The Use Of Bococizumab (PF-04950615; RN316) In Subjects With Heterozygous Familial HypercholesterolemiaCompletedNCT01968980Phase 3Results posted
- Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular EventsCompletedNCT01968967Phase 3Results posted
- Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular EventsCompletedNCT01968954Phase 3Results posted
- A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response ModelTerminatedNCT01965600Phase 1Results posted
- 13vPnC Multidose Vial Safety, Tolerability and Immunogenicity Study in Healthy Infants.CompletedNCT01964716Phase 3Results posted
- The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary VaccinationCompletedNCT01962207Phase 3Results posted
- Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGOCompletedNCT01959919Results posted
- A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) PatientsCompletedNCT01947894Results posted
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)CompletedNCT01945775Phase 3Results posted
- 5% Topical Ibuprofen (IBU) for Ankle SprainCompletedNCT01945034Phase 3Results posted
- Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLCCompletedNCT01945021Phase 2Results posted
- Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)CompletedNCT01942135Phase 3Results posted
- An Outpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Adjunctive Treatment Of Sub-Optimally Controlled Symptoms of SchizophreniaTerminatedNCT01939548Phase 2Results posted
- Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™VaccineCompletedNCT01939158Phase 3Results posted
- A Study Of PF-05212384 Plus FOLFIRI Versus Bevacizumab Plus FOLFIRI In Metastatic Colorectal CancerTerminatedNCT01937715Phase 1/2Results posted
- Drug Use Investigation for ToviazCompletedNCT01936870Results posted
- Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC PatientsCompletedNCT01934452Results posted
- Study to Evaluate the Long-term Antibody Persistence of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine (GSK134612) Versus Mencevax ACWY in Healthy Adolescents and Adults and Booster Response to MenACWY-TT Vaccine Administered at 10 Years Post-primary VaccinationCompletedNCT01934140Phase 3Results posted
- Study Of Two Dosing Regimens Of PF-04937319 Compared To An Approved Agent (Sitagliptin) In Patients With Type 2 DiabetesCompletedNCT01933672Phase 1Results posted
- Tofacitinib (Xeljanz) Special Investigation for Rheumatoid ArthritisCompletedNCT01932372Results posted
- Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS TumorsCompletedNCT01927341Phase 1/2Results posted
- Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL)TerminatedNCT01925612Phase 2Results posted
- A Study Of PF-05212384 Plus Irinotecan Vs Cetuximab Plus Irinotecan In Patients With KRAS And NRAS Wild Type Metastatic Colorectal CancerTerminatedNCT01925274Phase 2Results posted
- Multiple Dose Study Of PF-05231023 In Obese Adult SubjectsTerminatedNCT01923389Phase 1Results posted
- A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)CompletedNCT01920061Phase 1Results posted
- PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric PatientsTerminatedNCT01919996Phase 2Results posted
- A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall SurvivalCompletedNCT01917214Results posted
- A Study To Evaluate The Efficacy And Safety of The Investigational Drug PF-03446962 (A Monoclonal Antibody With Antiangiogenic Features) In Combination With Best Supportive Care Versus Placebo Plus Best Supportive Care In Patients Affected By Recurrent Liver CancerTerminatedNCT01911273Phase 2Results posted
- Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant MelanomaCompletedNCT01909453Phase 3Results posted
- Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008CompletedNCT01903733Not applicableResults posted
- Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy ChildrenCompletedNCT01900899Phase 3Results posted
- Special Investigation Of Genotropin Long Follow-Up For Patients With A Small For Gestational Age "Scoped for Japanese"CompletedNCT01897766Results posted
- Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed InfectionsCompletedNCT01893346Phase 1Results posted
- A Study Of PF-06263507 In Patients With Advanced Solid TumorsTerminatedNCT01891669Phase 1Results posted
- Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast CancerCompletedNCT01889238Phase 2Results posted
- MEK162 for Patients With RAS/RAF/MEK Activated TumorsCompletedNCT01885195Phase 2Results posted
- Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF InhibitorsCompletedNCT01882439Phase 3Results posted
- Use Of Fragmin In HemodialysisCompletedNCT01879618Phase 3Results posted
- Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator StudyCompletedNCT01877668Phase 3Results posted
- Study to Observe the Safety and Efficacy of Etanercept (Enbrel®) in Patients With Moderately Active Rheumatoid Arthritis in Every Day Clinical Practice in AustriaCompletedNCT01877239Results posted
- A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast CancerTerminatedNCT01876251Phase 1Results posted
- Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin LymphomaCompletedNCT01874054Phase 1/2Results posted
- Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)CompletedNCT01859949Phase 4Results posted
- A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01858389Phase 2Results posted